pharma news today obesity drugs glp-1 september 2025 2024 was a record year for trials and is already poised to take over IQVIA Early Bird: 2025 Revealed

Share your thoughts below To view or add a comment, sign in The Myocardial Infarction (Heart Attack) Drugs Market continues to grow steadily as cardiovascular diseases remain one of the leading causes of death worldwide

BPC-157: 0.5 mg daily, either as single dose or split 0.25 mg twice daily TB-500: 2-2.5 mg twice weekly (Monday/Thursday) totaling 4-5 mg per week Duration: 4-6 weeks loading phase, then 2-4 weeks maintenance Important: Use separate vials and syringes for each peptide

The level of eGFR can help detect early CKD, and decreasing levels of eGFR are considered the most characteristic sign of progressive kidney disease

This pharmacologic effect is intentional and contributes to the appetite suppression and weight loss benefits patients experience

it also has three times more antioxidants than red and green tea